Clinical Trial Update: A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022) [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety, pharmacokinetics, and preliminary efficacy of MK-0873 for plaque psoriasis and has completed with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriasis

Drugs mentioned

• MK-0873 (MK-0873)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Psoriasis, Plaque Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2014-06-11